Oakwood Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-47,673
| Closed | -$3.02M | – | 48 |
|
|
2019
Q3 | $3.02M | Sell |
47,673
-930
| -2% | -$59K | 1.34% | 34 |
|
|
2019
Q2 | $3.28M | Sell |
48,603
-520
| -1% | -$35.1K | 1.41% | 32 |
|
|
2019
Q1 | $3.19M | Sell |
49,123
-550
| -1% | -$35.8K | 1.34% | 35 |
|
|
2018
Q4 | $3.11M | Buy |
49,673
+235
| +0.5% | +$14.7K | 1.46% | 31 |
|
|
2018
Q3 | $3.82M | Buy |
49,438
+285
| +0.6% | +$22K | 1.55% | 32 |
|
|
2018
Q2 | $3.48M | Sell |
49,153
-605
| -1% | -$42.9K | 1.47% | 34 |
|
|
2018
Q1 | $3.75M | Buy |
49,758
+9,928
| +25% | +$748K | 1.6% | 34 |
|
|
2017
Q4 | $2.85M | Sell |
39,830
-10,485
| -21% | -$751K | 0.63% | 54 |
|
|
2017
Q3 | $4.08M | Buy |
50,315
+65
| +0.1% | +$5.27K | 0.95% | 46 |
|
|
2017
Q2 | $3.56M | Sell |
50,250
-1,850
| -4% | -$131K | 0.88% | 47 |
|
|
2017
Q1 | $3.54M | Buy |
52,100
+655
| +1% | +$44.5K | 0.88% | 50 |
|
|
2016
Q4 | $3.68M | Buy |
+51,445
| New | +$3.68M | 0.94% | 48 |
|
|
2014
Q4 | – | Sell |
-60,771
| Closed | -$6.47M | – | 96 |
|
|
2014
Q3 | $6.47M | Sell |
60,771
-11,584
| -16% | -$1.23M | 1.89% | 10 |
|
|
2014
Q2 | $6M | Buy |
72,355
+690
| +1% | +$57.2K | 1.81% | 11 |
|
|
2014
Q1 | $5.08M | Buy |
71,665
+1,560
| +2% | +$111K | 1.67% | 18 |
|
|
2013
Q4 | $5.27M | Buy |
70,105
+1,260
| +2% | +$94.6K | 1.75% | 12 |
|
|
2013
Q3 | $4.33M | Buy |
68,845
+3,410
| +5% | +$214K | 1.58% | 15 |
|
|
2013
Q2 | $3.36M | Buy |
+65,435
| New | +$3.36M | 1.33% | 28 |
|